Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mike McEwan"'
Autor:
Oscar M. Camacho, Andrew Hedge, Frazer Lowe, Nik Newland, Nathan Gale, Mike McEwan, Christopher Proctor
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Tobacco harm reduction strategies aim to substitute smoking with potentially reduced risk products (PRRPs) such as e-cigarettes and tobacco-heating products (THPs). The health benefits of switching from smoking to PRRPs is unknown. A randomised contr
Externí odkaz:
https://doaj.org/article/1fd7852ff53a4d9a821856021aea2177
Autor:
Nathan Gale, Mike McEwan, Alison C. Eldridge, Neil Sherwood, Edward Bowen, Simon McDermott, Emma Holmes, Andrew Hedge, Stuart Hossack, Oscar M. Camacho, Graham Errington, John McAughey, James Murphy, Chuan Liu, Christopher J. Proctor, Ian M. Fearon
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-18 (2017)
Abstract Background Smoking is a leading cause of numerous human disorders including lung cancer, chronic obstructive pulmonary disease, and atherosclerotic cardiovascular disease. The development of modified risk tobacco products (MRTPs) has been su
Externí odkaz:
https://doaj.org/article/262416f1d095480c9feef5dc6351bd08
Autor:
Christopher Proctor, Frazer Lowe, James Murphy, George Hardie, James K. Ebajemito, Mike McEwan, Nathan Gale, Nik Newland, Oscar M. Camacho
Publikováno v:
Internal and Emergency Medicine
Tobacco heating products (THPs) are a potentially safer alternative to combustible cigarette smoking. Through continued use, THPs may reduce smoking-related disease risk, whilst maintaining the sensorial experience and nicotine delivery sought by smo
Autor:
Nathan Gale, Ian M. Fearon, Mitchell F. Stiles, Alison Eldridge, Elaine K. Round, Mike McEwan
Publikováno v:
Regulatory Toxicology and Pharmacology. 100:25-34
E-cigarettes are battery-powered electronic devices from which users can inhale nicotine following its aerosolisation from a liquid solution. Some regulators and public health bodies consider e-cigarettes as potentially playing a major role in tobacc
Publikováno v:
F1000Research. 10:1293
Biomarkers of potential harm (BoPH) are indicators of biological perturbations which may contribute to the pathophysiology of disease. In this review, we critically assessed the published data on lung-related BoPH in human lung disease for potential
Autor:
Oscar M. Camacho, Simon McDermott, John McAughey, Chuan Liu, Emma Holmes, Graham Errington, Stuart Hossack, James Murphy, Edward Bowen, Alison Eldridge, Mike McEwan, Ian M. Fearon, Andrew Hedge, Christopher Proctor, Nathan Gale, Neil Sherwood
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-18 (2017)
BMC Public Health
BMC Public Health
Background Smoking is a leading cause of numerous human disorders including lung cancer, chronic obstructive pulmonary disease, and atherosclerotic cardiovascular disease. The development of modified risk tobacco products (MRTPs) has been suggested a
Autor:
Ian M. Fearon, Mitch Nides, Christopher Proctor, Nathan Gale, Christopher J. Shepperd, Kevin McAdam, Mike McEwan, Alison Eldridge, Oscar M. Camacho
Publikováno v:
American Journal of Health Behavior. 41:16-32
Objectives E-cigarettes could potentially play a major role in tobacco harm reduction by delivering nicotine in a vapor containing significantly fewer toxicants than cigarette smoke and may aid smoking behavior changes such as reduction or cessation.
Autor:
Nathan Gale, Frazer Lowe, Christopher Proctor, Oscar M. Camacho, Mike McEwan, Nik Newland, Andrew Hedge
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Tobacco harm reduction strategies aim to substitute smoking with potentially reduced risk products (PRRPs) such as e-cigarettes and tobacco-heating products (THPs). The health benefits of switching from smoking to PRRPs is unknown. A randomised contr
Autor:
Neil Sherwood, Chuan Liu, James Glew, Simon McDermott, Emma Holmes, Nathan Gale, Andrew Hedge, Stuart Hossack, Louise Wakenshaw, Edward Bowen, Ian M. Fearon, Mike McEwan, Christopher Proctor, Graham Errington, Alison Eldridge, Oscar M. Camacho, John McAughey, James Murphy
Publikováno v:
Nicotine & Tobacco Research
Background Smoking is a leading cause of numerous human disorders including pulmonary disease, cardiovascular disease, and cancer. Disease development is primarily caused by exposure to cigarette smoke constituents, many of which are known toxicants.
Autor:
Jim Shepperd, Francis Cheung, Mike McEwan, Johannes Engl, Gerhard Scherer, Bernhard Ramsauer, Katharina Sterz, Heinz-Werner Hagedorn, Graham Errington
Publikováno v:
Analytical and Bioanalytical Chemistry. 399:877-889
Polycyclic aromatic hydrocarbons (PAH) are products of the incomplete combustion of organic materials and, therefore, occur ubiquitously in the environment and also in tobacco smoke. Since some PAH have been classified as carcinogens, it is important